The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

18001–18025 of 18050

  • ModerateFDA (Drugs)·D-1409-2012·2012-07-11

    Teva Recalls Metoprolol Tartrate Tablets Due to Weight Variations

    Teva Pharmaceuticals is recalling 2,268 bottles of Metoprolol Tartrate 50 mg tablets in Ohio because some tablets may not meet weight specifications.

    Product
    Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-1407-2012·2012-07-11

    Sanofi Recalls Eloxatin Injection Due to Manufacturing Practice Deviations

    Sanofi-aventis is recalling 196,355 vials of Eloxatin (oxaliplatin) injection nationwide because the contract manufacturer failed to meet Good Manufacturing Practices.

    Product
    Eloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg, Rx only, Mfd. for: sanofi aventis US LLC Bridgewater, NJ 08807, NDC 0024-0590-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1408-2012·2012-07-11

    Sanofi-aventis Recalls Eloxatin Injection Due to Manufacturing Issues

    Sanofi-aventis is recalling Eloxatin (oxaliplatin) injection vials because the contract manufacturer had significant Good Manufacturing Practice issues.

    Product
    Eloxatin (OXALIplatin injection) 5 mg/mL injection, 100 mg, Rx only, Mfd. for: sanofi aventis US LLC Bridgewater, NJ 08807, NDC 0024-0591-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1403-2012·2012-07-11

    Watson Recalls Loxapine Succinate Capsules Due to Outdated Patient Outsert

    Watson Laboratories is recalling 7,262 bottles of Loxapine Succinate Capsules because an outdated patient outsert was used during packaging.

    Product
    Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1405-2012·2012-07-11

    Ranbaxy Recalls Subpotent Balnetar Therapeutic Tar Bath Coal Tar Product

    Ranbaxy Inc. is recalling Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5%, because the product failed to meet specifications for coal tar content.

    Product
    Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5% (from Coal Tar USP Solution, 7%), 7.5 oz bottle, Distributed by Ranbaxy, Jacksonville, FL 32257, NDC 10631-106-08
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1399-2012·2012-07-11

    Watson Loxapine Capsules Recalled for Outdated Patient Outsert

    Watson Laboratories is recalling 8,254 bottles of Loxapine Capsules 5mg because an outdated patient outsert was used during packaging.

    Product
    Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1402-2012·2012-07-11

    Watson Recalls Loxapine Capsules Due to Outdated Patient Outsert

    Watson Laboratories is recalling 18,902 bottles of Loxapine 50mg capsules because an outdated patient outsert was used during packaging.

    Product
    LOXAPINE — LOXAPINE (LOXAPINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1406-2012·2012-07-11

    Health Plus Super Colon Cleanse Recalled for Labeling Error

    Health Plus Incorporated is recalling Super Colon Cleanse capsules because the Drug Facts label incorrectly describes the active ingredient per dose instead of per capsule.

    Product
    Super Colon Cleanse, stimulant laxative, 140 mg of Senna per capsule, 25 doses, 100 capsules, Manufactured by: healthPLUS Inc. Chino, CA 91710 USA.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1404-2012·2012-07-11

    Imodium Multi-Symptom Relief Caplets Recalled for Defective Containers

    McNeil Consumer Healthcare is recalling Imodium Multi-Symptom Relief Caplets due to defective containers and damaged blister units.

    Product
    Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1395-2012·2012-07-04

    Lloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets

    Lloyd Inc is recalling 1,913,236 Thyro-Tab 0.75 mg tablets because they failed potency testing at the 6-month interval.

    Product
    Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1391-2012·2012-07-04

    Methylprednisolone Tablets Recalled for Potential Impurity Specification Failure

    Physicians Total Care Inc. is recalling Methylprednisolone Tablets, USP, 4 mg, due to potential failure to meet Impurity C specifications.

    Product
    Methylprednisolone Tablets, USP, 4 mg, 20 tablets per bottle, Repacked & Distributed by: Physicians Total Care Inc., Tulsa, OK 74146, NDC # 54868-2913-03
    Category
    Drug
    Distribution
    2 states
  • ModerateFDA (Drugs)·D-1394-2012·2012-07-04

    Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets

    Lloyd Inc is recalling 19,039 bottles of Levothroid 75 mcg tablets because the drug tested below the required potency level.

    Product
    Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1393-2012·2012-07-04

    Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets

    Lloyd Inc is recalling 19,166 bottles of Levothroid 50 mcg tablets because they failed potency testing at 9 months.

    Product
    Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01. Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1392-2012·2012-07-04

    Lloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets

    Lloyd Inc is recalling 1,924,297 bulk Thyro-Tab 0.050mg tablets because they failed potency testing at the 9-month interval. The product was distributed nationwide and to Puerto Rico.

    Product
    Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1397-2012·2012-07-04

    Teva Recalls Zeosa Oral Contraceptive Tablets Due to Impurity Concerns

    Teva Pharmaceuticals is recalling specific lots of Zeosa chewable oral contraceptive tablets because they may not meet impurity specifications.

    Product
    Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP, (chewable) 75 mg), 3 Blister Cards, 28 Tablets Each, Rx only, TEVA Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-2090-28 and 0093-2090-58, cartons…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1396-2012·2012-07-04

    Teva Recalls Mefloquine Hydrochloride Tablets Due to Weight Variations

    Teva Pharmaceuticals is recalling Mefloquine Hydrochloride 250 mg tablets because they may be underweight or overweight.

    Product
    MEFLOQUINE HYDROCHLORIDE — MEFLOQUINE HYDROCHLORIDE (MEFLOQUINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1398-2012·2012-07-04

    Shionogi Recalls Nisoldipine Extended Release Tablets for Dissolution Failure

    Shionogi Inc. is recalling Nisoldipine Extended Release Tablets, 17mg, because a specific lot failed USP dissolution testing requirements.

    Product
    Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for: Prasco Laboratories Mason OH 45040, Manufactured by SkyePharma production SAS 38297, Saint Quentin-Pallavier, France, NDC: 0677-1979-01
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-1386-2012·2012-06-27

    Physicians Total Care Recalls Morphine Sulfate Tablets Due to Labeling Error

    Physicians Total Care is recalling Morphine Sulfate tablets because bottles may be mislabeled, potentially containing the wrong formulation.

    Product
    Morphine Sulfate Immediate Release tablet, 30 mg/120 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, OK 74146-6234, NDC 54868-4973-00
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1385-2012·2012-06-27

    Physicians Total Care Recalls Morphine Sulfate Extended Release Tablets Due to Labeling Error

    Physicians Total Care is recalling Morphine Sulfate Extended Release tablets because bottles may be mislabeled as Immediate Release or vice versa.

    Product
    Morphine Sulfate Extended Release tablet, 30 mg, 60 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, Ok 74146-6234, NDC 54868-4033-00
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Devices)·Z-1824-2012·2012-06-27

    App Pharmaceuticals Recalls Heparin Lock Flush Solution Due to Documentation Issues

    App Pharmaceuticals is recalling Heparin Lock Flush Solution vials due to incomplete documentation of test results. The recall covers 133,150 vials distributed nationwide and in Puerto Rico.

    Product
    HEPARIN LOCK FLUSH SOLUTION, USP, 10 USP Units/mL, 1 mL Multiple Dose Vial, plastic vial, vial size 3 mL, NDC 63323-544-01, Product Code 504401, Rx only To maintain patency of an indwelling venipuncture device designed for intermittent injection or infusion therapy or blood…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1389-2012·2012-06-27

    Physicians Total Care Recalls Lipitor Tablets Due to Chemical Contamination

    Physicians Total Care is recalling specific lots of Lipitor (atorvastatin calcium) 40 mg tablets due to chemical contamination identified as 2,4,6 tribromoanisole.

    Product
    Lipitor (Atorvastatin calcium); 40 mg, 30 TABLETS, Rx only, Repacked & distributed: Physicians Total Care, Inc., Tulsa OK 74146, NDC 54868-4229-0
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-1387-2012·2012-06-27

    Kutol Hands Down Medicated Lotion Soap Recalled for Unapproved Dye

    Kutol Products Co Inc is recalling Hands Down Medicated Lotion Soap because it contains Red Dye #15, an ingredient not approved for use in drugs.

    Product
    Hands Down Medicated Lotion Soap, 1 gallon bottle, 4 gallons per case, Distributed by PCS Industries, Crestwood, IL, 60446
    Category
    Drug
    Distribution
    1 state